Home » Good Laboratory Practice for Nonclinical Studies
Product Image

Good Laboratory Practice for Nonclinical Studies

€61.50
Quantity:
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
14 days return policy Shipping & Delivery
Age Group_Uncategorized
Age Group_Uncategorized
Animal Care
Animal Studies
automatic-update
B01=Graham P. Bunn
Category1=Non-Fiction
Category=KJMQ
Category=MB
Category=MMG
Category=PDJ
Category=PDN
Category=PS
Category=TDCW
CFR
computer systems validation
Control Article
COP=United Kingdom
Delivery_Delivery within 10-20 working days
Disqualification Proceeding
Dose Formulation
electronic records management
electronic signature validation in laboratories
eq_bestseller
eq_business-finance-law
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_science
experimental protocol design
Facility SOPs
FDA GLPs
GLP Compliance
GLP Regulation
GLP Requirement
GLP Study
GLP Toxicology Study
laboratory data integrity
Language_English
Marketing Permit
Multisite Studies
Nonclinical Laboratory Studies
Nonclinical Safety Studies
Nonclinical Study
OECD GLP
PA=Available
Price_€50 to €100
PS=Active
Public Health Service Act
QAU
regulatory compliance
softlaunch
Sop Deviation
Study Director
Test Article
Testing Facility Management
toxicology research methods

Product details

  • ISBN 9781032381152
  • Weight: 453g
  • Dimensions: 156 x 234mm
  • Publication Date: 09 Oct 2024
  • Publisher: Taylor & Francis Ltd
  • Publication City/Country: GB
  • Product Form: Paperback
  • Language: English
Secure checkout Fast Shipping Easy returns
Description

The GLP regulations have been enacted since 1978 and are currently under a proposed FDA amendment to revise terminology and accommodate other changes relating to advances in technology related to the industry. This book provides a unique opportunity to access interpretation of the 21CFR58 regulatory requirements from leading industry experts with a vast knowledge and expertise in their fields. The approach used takes the regulations, provides interpretations and references to examples and regulatory actions. Data integrity and the use of electronic systems in compliance with 21CFR11 Electronic Records: Electronic Signatures are also discussed.

• Unique volume covering FDA inspections of GLP facilities

• Provides a detailed interpretation of GLP Regulations

• Presents the latest on electronic data management in GLP

• Describes GLP and computer systems validation

• Can be referenced repeatedly in supporting daily hands on implementation of the CFR requirements
About

Graham P. Bunn has been the president of GB Consulting LLC, in Pennsylvania, since 2000 and provides regulatory compliance guidance and technical consulting services for pharmaceutical, biotechnology and other FDA related industries in quality systems, regulatory action (FDA483, Warning Letter, Consent Decree) remediations and training. Before founding GB Consulting LLC, Graham gained extensive good manufacturing practices (GMP) and FDA inspection experience through his work in the pharmaceutical industry with SmithKline Beecham PLC (GlaxoSmithKline PLC), Wyeth Pharmaceuticals (Pfizer), and Astra Merck Inc. (AstraZeneca PLC). His career experience includes management positions and responsibilities as a corporate compliance quality auditor and also in quality assurance, validation, and clinical trials manufacturing and packaging. He has developed and facilitated numerous highly interactive learning and training workshops worldwide including Aseptic Training Programs, Batch Record Reviews, QA on the Floor and aseptic training support for 503B Compounding Centers. Graham is the editor of Good Manufacturing Practices for Pharmaceuticals and author of several book chapters and journal articles. Graham received a BSc in pharmacy from Brighton University, England, and a MSc in quality assurance and regulatory affairs from Temple University, Philadelphia and is a member of the Regulatory Affairs Professional Society (RAPS).